
PHAR
Healthcare · Biotechnology · $891.8M market cap
$12.60-0.35 (-2.7%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -44.1% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 27, 2026 | Before the open | 0.33 | 0.30 | -9.1% |
| Jul 30, 2026 | Before the open | 0.20 | 0.02 | -90.0% |
| May 7, 2026 | Before the open | 0.01 | -0.07 | -800.0% |
| Mar 12, 2026 | Time not confirmed | 0.01 | 0.07 | +498.3% |
| Nov 6, 2025 | Before the open | -0.13 | 0.01 | +108.0% |
| Jul 31, 2025 | Before the open | -0.01 | 0.01 | +200.0% |
| May 8, 2025 | Before the open | -0.02 | -0.02 | 0.0% |
| Mar 12, 2025 | Before the open | 0.01 | 0.01 | -41.2% |
| Oct 24, 2024 | Before the open | -0.00 | -0.02 | -512.0% |
| Aug 1, 2024 | Before the open | -0.00 | -0.02 | -785.0% |
| May 8, 2024 | Before the open | 0.01 | -0.02 | -300.0% |
| Mar 14, 2024 | Before the open | 0.00 | -0.04 | -1002.2% |
| Oct 26, 2023 | Before the open | -0.01 |
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja…
| 0.01 |
| +200.0% |
| Aug 3, 2023 | Before the open | -0.02 | 0.01 | +150.0% |
| May 11, 2023 | Before the open | -0.17 | -0.02 | +88.2% |
| Mar 16, 2023 | Time not confirmed | -0.21 | -0.20 | +2.4% |
| Oct 27, 2022 | Before the open | 0.40 | 0.01 | -97.5% |
| Aug 4, 2022 | Before the open | 0.01 | 0.01 | 0.0% |
| May 12, 2022 | Before the open | 0.05 | 0.01 | -80.0% |
| Mar 17, 2022 | Time not confirmed | 0.02 | 0.01 | -25.0% |
| Oct 28, 2021 | Time not confirmed | 0.04 | -0.00 | -101.2% |
| Aug 5, 2021 | Time not confirmed | 0.10 | 0.05 | -47.6% |
| May 13, 2021 | Time not confirmed | 0.16 | 0.16 | -1.9% |
| Mar 4, 2021 | Time not confirmed | 0.11 | 0.11 | +4.0% |
| Oct 29, 2020 | Time not confirmed | 0.12 | 0.01 | -89.0% |
| Jul 30, 2020 | Time not confirmed | 0.15 | 0.01 | -92.2% |
| May 14, 2020 | Time not confirmed | 0.12 | 0.02 | -86.8% |
| Mar 5, 2020 | Time not confirmed | 0.20 | 0.01 | -94.0% |
| Oct 24, 2019 | Time not confirmed | 0.18 | 0.02 | -88.7% |
| Jul 26, 2019 | Time not confirmed | 0.12 | 0.02 | -85.6% |
| Jun 30, 2019 | Time not confirmed | 0.00 | 0.01 | — |
| Mar 31, 2019 | Time not confirmed | 0.00 | 0.01 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | 0.03 | — |
| Sep 30, 2018 | Time not confirmed | 0.00 | 0.01 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | 0.01 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | 0.01 | — |